Old Web
English
Sign In
Acemap
>
authorDetail
>
Schalm
Schalm
Medicine
Gastroenterology
Internal medicine
chronic hepatitis
Randomized controlled trial
5
Papers
66
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Schweizerisches Register für TNF-α-Blocker bei Kindern und Jugendlichen mit rheumatologischen Erkrankungen
2012
Praxis Journal of Philosophy
Sauvain
Schalm
Berthet
Bolz
Höfer
Kaiser
Saurenmann
Bolt
Show All
Source
Cite
Save
Citations (2)
Interferon-α therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy
2000
Journal of Viral Hepatitis
Heijtink
Osterhaus
Schalm
Show All
Source
Cite
Save
Citations (34)
glycyrrhizin as a potential treatment for chronic hepatitis C: REVIEW: GLYCYRRHIZIN FOR HEPATITIS C
1998
Alimentary Pharmacology & Therapeutics
T. G.J. van Rossum
Vulto
R.A. de Man
Brouwer
Schalm
Show All
Source
Cite
Save
Citations (0)
A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg
1998
Alimentary Pharmacology & Therapeutics
H. J. F. Van Hoogstraten
M. B. M. De Smet
Renooij
Breed
Engels
J.W. den Ouden-Muller
Rijk
Zwertbroek
G. P. Van Berge Henegouwen
Schalm
H.R. van Buuren
Show All
Source
Cite
Save
Citations (30)
A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg: URSODEOXYCHOLIC ACID FOR PBC
1998
Alimentary Pharmacology & Therapeutics
H. J. F. Van Hoogstraten
M.B.M. de Smet
Renooij
Breed
Engels
J.W. den Ouden-Muller
Rijk
Zwertbroek
G. P. van Berge Henegouwen
Schalm
H.R. van Buuren
Show All
Source
Cite
Save
Citations (0)
1